NEW YORK (GenomeWeb News) — Bar Harbor Biotechnology has closed a “multi-million dollar” round of Series A financing and plans to use the cash to market its first product, the company said Tuesday.
Bar Harbor Biotechnology, based in Trenton, Maine, is developing a suite of gene-expression products that includes bioanalysis software, qPCR arrays, and bioinformatics applications for gene-expression experiments.
Bar Harbor, which spun off from the Jackson Laboratory in 2006, said it plans to launch its first commercial product on Oct. 1. It was not immediately clear what that product will be.
Leading the investment round was Borealis Ventures, a seed capital company based in Hanover, NH, that focuses on New England startups. Village Ventures, an early-stage investment specialist based in Williamstown, Mass., contributed to the round.